Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasms 1NSCLC 1Mouth Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 9Magnetic Resonance Spectroscopy 8Drug Therapy 7Carboplatin 7osimertinib 6Tomography, X-Ray Computed 5Pemetrexed 5Educational Status 5Interviews as Topic 4Early Intervention, Educational 4Cisplatin 4Blood Specimen Collection 4cemiplimab 3Methods 3Injections 3Exercise 3pembrolizumab 2durvalumab 2atezolizumab 2anlotinib 2aflutinib 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy 2Radiosurgery 2Observation 2Nivolumab 2Magnetic Resonance Imaging 2Immunotherapy 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lung Neoplasms × Chemoradiotherapy × Clear all
NCT05904015 2023-06-15

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
80 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡